Top Vaccines companies in South Korea by Net Income Margin

This ranking features the top 19 Vaccines companies in South Korea ranked by Net Income Margin, averaging a Net Income Margin of -231.17%, for February 04, 2025.
#
Name
Net Income Margin
Reported Date
Stock Price
Change
Price (30 days) Country
1
24.61%
Dec. 31, 2023 USD 119.86 -2.20%

South Korea

2
8.11%
Dec. 31, 2023 USD 89.76 -4.42%

South Korea

3
6.47%
Dec. 31, 2023 USD 11.62 -0.90%

South Korea

4
6.04%
Dec. 31, 2023 USD 32.21 -3.61%

South Korea

5
5.12%
Dec. 31, 2023 USD 65.38 -0.04%

South Korea

6
4.41%
Dec. 31, 2023 USD 77.77 -3.69%

South Korea

7
0.18%
Dec. 31, 2023 USD 15.77 -2.26%

South Korea

8
-1.64%
Dec. 31, 2023 USD 88.80 -5.65%

South Korea

9
-2.63%
Dec. 31, 2023 USD 9.61 -3.70%

South Korea

10
-3.49%
Dec. 31, 2023 USD 240.05 -5.25%

South Korea

11
-20.01%
Dec. 31, 2023 USD 8.83 4.03%

South Korea

12
-101.15%
Dec. 31, 2023 USD 3.75 -3.31%

South Korea

13
-111.94%
Dec. 31, 2023 USD 10.77 -3.15%

South Korea

14
-193.44%
Dec. 31, 2023 USD 1.42 -2.25%

South Korea

15
-241.69%
Dec. 31, 2023 USD 4.40 -2.27%

South Korea

16
-517.04%
Dec. 31, 2023 USD 1.65 -4.10%

South Korea

17
-740.68%
Dec. 31, 2023 USD 1.23 -3.88%

South Korea

18
-1,002.81%
Dec. 31, 2023 USD 1.61 -1.19%

South Korea

19
-1,510.71%
Dec. 31, 2023 USD 3.04 -3.81%

South Korea

Frequently Asked Questions
  • Which Vaccines company in South Korea has the highest Net Income Margin ?

    The Vaccines company in South Korea with the highest Net Income Margin is Celltrion, Inc. (KSE: 068270.KS) at 24.61%.

  • Which Vaccines company in South Korea has the lowest Net Income Margin ?

    The Vaccines company in South Korea with the lowest Net Income Margin is Genexine, Inc. (KOSDAQ: 095700.KQ) at -1,510.71%.

SV Wall Street